CRISPR Therapeutics Statistics
NASDAQ: CRSPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
39.10+0.17 (+0.44%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CRISPR Therapeutics by the numbers
CRISPR Therapeutics has a market capitalization of $3.79 billion based on 97.00M shares outstanding. With trailing EPS of $-4.73, CRISPR Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.9% below its 50-day average and 25.2% below its 200-day average.
Average daily trading volume is 1.74M shares, or about $68.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRSP valuation vs. peer median
| Metric | CRSP | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.79B | $3.07B | +23% |
| Avg. volume | 1.74M | 2.12M | -18% |
Peer median across 8 companies: TARS, RLAY, IOVA, ADPT, DNLI, VCEL, ADMA, BEAM.
Valuation
- Market cap
- $3.79B
- Price / sales (latest FY)
- 1,080.55
- EPS (TTM)
- $-4.73
- Shares outstanding
- 97.00M
Price and trading
- Previous close
- 38.93
- Open
- 38.18
- Day range
- 38.18 – 40.17
- 52-week range
- 38.15 – 63.45
- 52-week change
- -22.16%
- Beta
- —
- Volume
- 3.32M
- Average volume
- 1.74M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 3.79B
- Forward Pe
- -10.61
- Eps
- -4.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 63.45
- Week52 Low
- 38.15
- Avg Volume
- 1.74M
- Shares Outstanding
- 97.00M
- Ma50
- 50.71
- Ma200
- 52.27
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -38.38%
- Pct From52w Low
- 2.49%